The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses

Nika Lovšin,Bhavani Gangupam,Martina Bergant Marušič

DOI: https://doi.org/10.3390/pathogens13030187

IF: 3.7

2024-02-20

Pathogens

Abstract:APOBEC3 proteins are cytidine deaminases that play a crucial role in the innate immune response against viruses, including DNA viruses. Their main mechanism for restricting viral replication is the deamination of cytosine to uracil in viral DNA during replication. This process leads to hypermutation of the viral genome, resulting in loss of viral fitness and, in many cases, inactivation of the virus. APOBEC3 proteins inhibit the replication of a number of DNA tumour viruses, including herpesviruses, papillomaviruses and hepadnaviruses. Different APOBEC3s restrict the replication of different virus families in different ways and this restriction is not limited to one APOBEC3. Infection with DNA viruses often leads to the development and progression of cancer. APOBEC3 mutational signatures have been detected in various cancers, indicating the importance of APOBEC3s in carcinogenesis. Inhibition of DNA viruses by APOBEC3 proteins appears to play a dual role in this process. On the one hand, it is an essential component of the innate immune response to viral infections, and, on the other hand, it contributes to the pathogenesis of persistent viral infections and the progression of cancer. The current review examines the complex interplay between APOBEC3 proteins and DNA viruses and sheds light on the mechanisms of action, viral countermeasures and the impact on carcinogenesis. Deciphering the current issues in the interaction of APOBEC/DNA viruses should enable the development of new targeted cancer therapies.

microbiology

What problem does this paper attempt to address?

The paper primarily explores the complex interactions between APOBEC3 proteins and DNA tumor viruses. APOBEC3 proteins are a class of cytidine deaminases that play a crucial role in the innate immune response by deaminating cytidine to uridine in viral DNA, thereby restricting viral replication. This process leads to a high mutation rate in the viral genome, reducing the virus's adaptability and activity. APOBEC3 proteins can inhibit the replication of various DNA tumor viruses, such as herpesviruses, papillomaviruses, and hepatitis viruses.

Infection with DNA viruses often leads to the development and progression of cancer. Studies have found that the mutational signature of APOBEC3 is prevalent in various cancers, indicating that APOBEC3 plays an important role in the carcinogenic process. The inhibitory effect of APOBEC3 on DNA viruses has a dual impact: on one hand, it is an essential component of the innate immune response against viral infections; on the other hand, it also promotes the pathological process of persistent viral infections and the development of cancer. This paper reviews the complex interaction mechanisms between APOBEC3 proteins and DNA viruses, revealing viral countermeasures and their impact on the carcinogenic process, and discusses the importance of decoding these interactions for developing new targeted cancer therapies.